Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Breast 1

Conditions

Breast Neoplasms 2Thyroid Neoplasms 1Sleep Apnea, Obstructive 1Rhinitis, Allergic, Seasonal 1Pulmonary Fibrosis 1Pulmonary Embolism 1Pulmonary Disease, Chronic Obstructive 1Mesothelioma 1Lung Neoplasms 1Lung Diseases, Interstitial 1Liver Neoplasms 1Hypertension, Pulmonary 1Emphysema 1Cystic Fibrosis 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Bronchiectasis 1Asthma 1Asbestosis 1

Interventions

Sorafenib 3vandetanib 2alectinib 2Sodium 2Magnetic Resonance Spectroscopy 2Imatinib Mesylate 2Bevacizumab 2tremelimumab 1temsirolimus 1ponatinib 1perflutren 1pembrolizumab 1methyl N-acetylsibirosaminide 1lenvatinib 1gallium 68 PSMA-11 1fosbretabulin 1durvalumab 1combretastatin 1cobimetinib 1cabozantinib 1X-Rays 1Valproic Acid 1Thyroxine 1Technetium Tc 99m Sestamibi 1Sirolimus 1Radiofrequency Ablation 1Presenilin-1 1Paclitaxel 1PLX8394 1Lubricant Eye Drops 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Thyroid Neoplasms × perflutren × Clear all
NCT04136912 2025-10-06

3-D Super Resolution Ultrasound Microvascular Imaging

UNC Lineberger Comprehensive Cancer Center

Phase 2 Terminated
27 enrolled 12 charts
BreastHead & Neck

Breast Neoplasms, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡